These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25603952)

  • 1. Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3.
    Diao J; Yang X; Song X; Chen S; He Y; Wang Q; Chen G; Luo C; Wu X; Zhang Y
    Med Oncol; 2015 Feb; 32(2):453. PubMed ID: 25603952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression.
    Gao Y; Xu H; Li N; Wang H; Ma L; Chen S; Liu J; Zheng Y; Zhang Y
    Cell Commun Signal; 2020 Jul; 18(1):106. PubMed ID: 32641056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.
    Gobbo J; Marcion G; Cordonnier M; Dias AMM; Pernet N; Hammann A; Richaud S; Mjahed H; Isambert N; Clausse V; Rébé C; Bertaut A; Goussot V; Lirussi F; Ghiringhelli F; de Thonel A; Fumoleau P; Seigneuric R; Garrido C
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26598503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer.
    Li H; Chen X; Zheng S; Han B; Zhang X; Zheng X; Lu Y; Sun Q; Hu X; Wu J
    J Transl Med; 2024 Sep; 22(1):821. PubMed ID: 39227816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation.
    Lee JM; Kim EK; Seo H; Jeon I; Chae MJ; Park YJ; Song B; Kim YS; Kim YJ; Ko HJ; Kang CY
    Eur J Immunol; 2014 Jun; 44(6):1672-84. PubMed ID: 24659444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axitinib augments antitumor activity in renal cell carcinoma via STAT3-dependent reversal of myeloid-derived suppressor cell accumulation.
    Yuan H; Cai P; Li Q; Wang W; Sun Y; Xu Q; Gu Y
    Biomed Pharmacother; 2014 Jul; 68(6):751-6. PubMed ID: 25081318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression.
    Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R
    J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
    Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
    Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway.
    Yan D; Yang Q; Shi M; Zhong L; Wu C; Meng T; Yin H; Zhou J
    Eur J Immunol; 2013 Nov; 43(11):2943-55. PubMed ID: 23897117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
    Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
    Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
    Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
    Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
    Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
    Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow cells are differentiated into MDSCs by BCC-Ex through down-regulating the expression of CXCR4 and activating STAT3 signalling pathway.
    Liu QW; Chen Y; Li JY; Xiao L; Zhang WJ; Zhao JL; Gu HC; Wu HY; Zuo GS; Deng KY; Xin HB
    J Cell Mol Med; 2021 Jun; 25(12):5497-5510. PubMed ID: 33955151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma.
    Zhao Q; Guo J; Wang G; Chu Y; Hu X
    Oncotarget; 2017 Jan; 8(1):1668-1677. PubMed ID: 27926489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
    Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
    Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of myeloid-derived suppressor cells by tumor exosomes.
    Xiang X; Poliakov A; Liu C; Liu Y; Deng ZB; Wang J; Cheng Z; Shah SV; Wang GJ; Zhang L; Grizzle WE; Mobley J; Zhang HG
    Int J Cancer; 2009 Jun; 124(11):2621-33. PubMed ID: 19235923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.
    Pinton L; Solito S; Damuzzo V; Francescato S; Pozzuoli A; Berizzi A; Mocellin S; Rossi CR; Bronte V; Mandruzzato S
    Oncotarget; 2016 Jan; 7(2):1168-84. PubMed ID: 26700461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.
    Jiang XL; Zhang Y; Tan B; Luo CL; Wu XH
    Neoplasma; 2014; 61(4):416-23. PubMed ID: 24645843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
    Hong EH; Chang SY; Lee BR; Kim YS; Lee JM; Kang CY; Kweon MN; Ko HJ
    Int J Cancer; 2013 Jun; 132(12):2839-48. PubMed ID: 23184679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.